ByDr. Brennan Commerford, D.C.·Last reviewed: April 2026
All Ingredients
Specialty1 form

5-HTP

Preferred Form
5-HTP
Form Score
100/100Top Tier
Evidence Level
Moderate Evidence

The 5-HTP form we carry

See how we score it — absorption, bioavailability & formulary tier

View score

Quick Answer

Which form of 5-HTP do we use?

5-HTP is the form of 5-HTP we carry — the only form in our formulary, recommended for its exceptional bioavailability.

All Forms of 5-HTP

FormTierForm ScoreDose RangeUnit
5-HTPPreferred
100/100Top Tier
——

Absorption by Form

Top Tier
5-HTP
100/100

What is 5-HTP?

5-HTP is a Specialty supplement available in 1 form.

FormulaForge carries a single form of 5-HTP, so there is no form to choose here. Forms on the market do differ in how well they absorb, which is why it is worth checking the form named on any product label.

The Form of 5-HTP We Carry

5-HTP Preferred (Preferred Form) has a bioavailability rating of high absorption.

What the Research Shows

5-HTP (5-hydroxytryptophan) is the direct precursor to serotonin, crossing the blood-brain barrier more efficiently than L-tryptophan. Clinical research supports its use for mood support and sleep quality, with multiple trials demonstrating measurable increases in serotonin metabolites. It is derived from Griffonia simplicifolia seed extract.

Steady-state oral 5-HTP systemic availability ranged 47-84% (mean 69.2% ± 4.7 SEM) across 5 patients receiving a decarboxylase inhibitor; dose-independent linear pharmacokinetics; time to peak plasma concentration 1.8-3.3 hours. PMID: 6966118
In 5 healthy volunteers dosed IV and orally with carbidopa pretreatment, oral bioavailability was 48% ± 15 (SD); biological half-life 2.2-7.4 hours; plasma clearance 0.10-0.23 L/kg/hour. A separate 8-subject arm showed carbidopa pretreatment significantly increased the extent of absorption of unchanged 5-HTP. PMID: 6187038
Direct proportionality between plasma 5-HTP and lumbar cerebrospinal-fluid 5-HTP concentrations in patients on steady-state treatment; 19% of circulating 5-HTP bound to serum proteins; preliminary comparison suggests carbidopa is superior to benserazide as the co-administered decarboxylase inhibitor. PMID: 6182005

How to Choose the Right Form

5-HTP is classified as Preferred Form by FormulaForge — our top recommendation for 5-HTP. It carries a bioavailability rating of high absorption, meaning more of the active compound reaches your tissues per dose unit compared to lower-rated forms.

When choosing a 5-HTP supplement, read the label for the specific form name — that is what determines how much you actually absorb. Preferred Forms have the strongest research-backed evidence for efficient absorption.

Other forms may be appropriate depending on individual goals, cost considerations, and your healthcare provider’s guidance. The best form for you depends on your specific health needs.

Dosing & Safety

Individual dose requirements vary based on health goals, body weight, and existing nutrient intake. Your healthcare provider can help you determine an appropriate amount of 5-HTP for you.

Side Effects: Consult your healthcare provider regarding tolerability, particularly at higher doses.

These statements are based on structure/function research and have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.

The Science

The following studies and findings inform FormulaForge classifications for 5-HTP:

Steady-state oral 5-HTP systemic availability ranged 47-84% (mean 69.2% ± 4.7 SEM) across 5 patients receiving a decarboxylase inhibitor; dose-independent linear pharmacokinetics; time to peak plasma concentration 1.8-3.3 hours. PMID: 6966118
In 5 healthy volunteers dosed IV and orally with carbidopa pretreatment, oral bioavailability was 48% ± 15 (SD); biological half-life 2.2-7.4 hours; plasma clearance 0.10-0.23 L/kg/hour. A separate 8-subject arm showed carbidopa pretreatment significantly increased the extent of absorption of unchanged 5-HTP. PMID: 6187038
Direct proportionality between plasma 5-HTP and lumbar cerebrospinal-fluid 5-HTP concentrations in patients on steady-state treatment; 19% of circulating 5-HTP bound to serum proteins; preliminary comparison suggests carbidopa is superior to benserazide as the co-administered decarboxylase inhibitor. PMID: 6182005

Dosing Guidance

Individual dose requirements for 5-HTP vary based on health goals, body weight, and existing dietary intake. A qualified healthcare provider can help you determine an appropriate amount for you.

Frequently Asked Questions

Which form of 5-HTP is in our formulary?
Our formulary carries a single form of 5-HTP: 5-HTP. It has exceptional bioavailability, meaning your body absorbs and uses it efficiently.
How much 5-HTP should I take?
Dosing for 5-HTP varies based on the specific form, your health goals, and individual factors. Consult a qualified healthcare provider for personalized guidance.
What does 5-HTP support?
5-HTP is commonly used to support Specialty. Research suggests it plays a role in several physiological pathways. As with all supplements, these statements have not been evaluated by the Food and Drug Administration and 5-HTP is not intended to diagnose, treat, cure, or prevent any disease.
Is 5-HTP safe?
5-HTP is generally well-tolerated when taken at research-supported doses. As with any supplement, individual responses vary. Consult a qualified healthcare provider before use, especially if you are pregnant, nursing, have a medical condition, or take medications. These statements have not been evaluated by the Food and Drug Administration.

Ready to formulate with 5-HTP?

Our formulary recommends 5-HTP for optimal bioavailability. Build your personalized formula now.

Start My Formula

Compare & Learn More

References

  1. Steady-state oral 5-HTP systemic availability ranged 47-84% (mean 69.2% ± 4.7 SEM) across 5 patients receiving a decarboxylase inhibitor; dose-independent linear pharmacokinetics; time to peak plasma concentration 1.8-3.3 hours. PubMed DOI
  2. In 5 healthy volunteers dosed IV and orally with carbidopa pretreatment, oral bioavailability was 48% ± 15 (SD); biological half-life 2.2-7.4 hours; plasma clearance 0.10-0.23 L/kg/hour. A separate 8-subject arm showed carbidopa pretreatment significantly increased the extent of absorption of unchanged 5-HTP. PubMed DOI
  3. Direct proportionality between plasma 5-HTP and lumbar cerebrospinal-fluid 5-HTP concentrations in patients on steady-state treatment; 19% of circulating 5-HTP bound to serum proteins; preliminary comparison suggests carbidopa is superior to benserazide as the co-administered decarboxylase inhibitor. PubMed DOI

FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.